[Hopes and experiences in the treatment of severe pulmonary hypertension].
Monserrat
Lorenzo
L
Penas Lado
Manuel
M
Castro-Beiras
Alfonso
A
D000959:Antihypertensive Agents / Q000627:therapeutic use; D019332:Endothelin-1 / Q000037:antagonists & inhibitors; D011464:Epoprostenol / Q000627:therapeutic use; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones; D014665:Vasodilator Agents / Q000627:therapeutic use
D000959:Antihypertensive Agents; D019332:Endothelin-1; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate; D011464:Epoprostenol